RNA interference targeting sensitive-to-apoptosis gene potentiates doxorubicin- and staurosporine-induced apoptosis of PC3 cells

Anticancer Research

Volumn 33, Issue 3, 2013, Pages 847-856

  Yang, Eun Sun ^a   Huh, Yun Jeong ^a   Park, Jeen Woo ^a  

^a Kyungpook National University   (South Korea)

Author keywords

Anticancer agents; Antioxidant protein; Apoptosis; PC3 cells; Redox status; SiRNA

Indexed keywords

ACETYLCYSTEINE; DOXORUBICIN; PROTEIN; REACTIVE OXYGEN METABOLITE; SENSITIVE TO APOPTOSIS GENE PROTEIN; SMALL INTERFERING RNA; STAUROSPORINE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL LEVEL; DRUG POTENTIATION; DRUG SENSITIVITY; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; MOLECULARLY TARGETED THERAPY; PRIORITY JOURNAL; PROSTATE CANCER; RNA INTERFERENCE;

ACETYLCYSTEINE; APOPTOSIS; CELL LINE, TUMOR; DOXORUBICIN; HUMANS; MALE; PROSTATIC NEOPLASMS; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; RNA, SMALL INTERFERING; STAUROSPORINE; UBIQUITIN-PROTEIN LIGASES;

EID: 84875911169     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Smets LA: Programmed cell death (apoptosis) and response to anticancer drugs. Anticancer Drugs 5: 3-9, 1994.
2. Wang J and Yi J: Cancer cell killing via ROS. Cancer Biol Ther 7: 1875-1884, 2008.
3. Mansat-de Mas V, Bezombes C, Quillet-Mary A, Bettaieb A, D'orgeix AT, Laurent G and Jaffrezou JP: Implication of radical oxygen species in ceramide generation, c-Jun N-terminal kinase activation and apoptosis induced by daunorubicin. Mol Pharmacol 56: 867-874, 1999.
4. Sordet O, Goldman A and Pommier Y: Topoisomerase II and tublin inhibitors both induce the formation of apoptotic topoisomerase I cleavage complexs. Mol Cancer Ther 12: 3139-3144, 2006.
5. Verhaegen S, McGowan AJ, Brophy AR, Fernandes RS and Cotter TG: Inhibition of apoptosis by antioxidants in the human HL-60 leukemia cell line. Biochem Pharmacol 50: 1021-1029, 1995.
6. Ricci JE, Munoz-Pinedo C, Fitzgerald P, Bailly-Maitre B, Perkins GA, Yadava N, Scheffler IE, Ellisman MH and Green DR: Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain. Cell 117: 773-786, 2004.
7. Trachootham D, Lu W, Ogasawara MA, Nilsa RD and Huang P: Redox regulation of cell survival. Antioxid Redox Signal 10: 1343-1374, 2008.
8. Kil IS, Kim SY, Lee SJ and Park J-W: Small interfering RNAmediated silencing of mitochondrial NADP+-dependent isocitrate dehydrogenase enhances the sensitivity of HeLa cells toward tumor necrosis factor-α and anticancer drugs. Free Radic Biol Med 43: 1197-1207, 2007.
9. Lee JH, Kim SY, Kil IS and Park J-W: Regulation of ionizing radiation-induced apoptosis by mitochondrial NADP+-dependent isocitrate dehydrogenase. J Biol Chem 282: 13385-13394, 2007.
10. Jia L, Yang J, Hao X, Zheng M, He H, Xiong X, Xu L and Sun Y: Validation of SAG/RBX2/ROC2 E3 ubiqutin ligase as an anticancer and radiosensitizing target. Clin Cancer Res 16: 814-824, 2010.
11. Tan M, Zhu Y, Kovacev J, Zhao Y, Pan Z-Q, Spitz DR and Sun Y: Disruption of Sag/Rbx2/Roc2 induces radiosensitization by increasing ROS levels and blocking Nf-κB activation in mouse embryonic stem cells. Free Radic Biol Med 49: 976-983, 2010.
12. Duan H, Wang Y, Aviram M, Swaroop M, Loo JA and Sun Y: SAG, a novel zinc ring finger protein that protects cells from apoptosis induced by redox agents. Mol Cell Biol 19: 3145-3155, 1999.
13. Swaroop M, Bian J, Aviram M, Duan H, Bisgaier CL, Loo JA and Sun Y: Expression, purification, and biochemical characterization of SAG, a ring finger redox-sensitive protein. Free Radic Biol Med 27: 193-202, 1999.
14. Kim SY, Bae YS and Park J-W: Thiol-linked peroxidase activity of human sensitive to apoptosis gene (SAG) protein. Free Rad Res 36: 73-78, 2002.
15. Tan M, Gallegos JR, Gu Q, Huang Y, Li J, Jin Y, Lu H and Sun Y: SAG/ROC-SCF β-TrCP E3 ubiquitin ligase promotes procaspase- 3 degradation as a mechanism of apoptosis protection. Neoplasia 8: 1042-1054, 2006.
16. Yang ES, Huh YJ and Park J-W: Knockdown of sensitive to apoptosis gene by small interfering RNA enhances the sensitivity of PC3 cells toward actinomycin D and etoposide. Free Rad Res 44: 864-870, 2010.
17. Stanton RC and Seifter JL: Epidermal growth factor rapidly activates the hexose monophosphate shunt in kidney cells. Am J Physiol 254: C267-C271, 1998.
18. Tak JK and Park J-W: The use of ebselen for radioprotection in cultured cells and mice. Free Radic Biol Med 46: 1177-1185, 2009.
19. Struthers I, Patel R, Clark J and Thomas S: Direct detection of 8- oxodeoxyguanosine and 8-oxoguanine by avidin and its analogues. Anal Biochem 255: 20-31, 1998.
20. Okimoto Y, Watanabe A, Niki E, Yamashita T and Noguchi N: A novel fluorescent probe diphenyl-1-pyrenylphosphine to follow lipid peroxidation in cell membranes. FEBS Lett 474: 137-140, 2000.
21. Pastorino JG, Simbula G, Yamamoto K, Glascott PA, Rothman RJ and Farber JL: The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition. J Biol Chem 271: 29792-29798, 1996.
22. Williams JM, Lea N, Nord JM, Roberts LM, Milford DV and Taylor CM: Comparison of ribosome-inactivating proteins in the induction of apoptosis. Toxicol Lett 91: 121-127, 1997.
23. Sundaresan M, Yu ZX, Ferrans CJ, Irani K and Finkel T: Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270: 296-299, 1995.
24. Carvalho C, Santos RX, Cardoso S, Correia S, Oliveira PJ, Santos MS and Moreira PI: Doxorubicin: The good, the bad and the ugly effect. Curr Med Chem 16: 3267-3285, 2009.
25. Injac R, Radic N, Govedarica B, Perse M, Cerar A, Djordjevic A and Strukelj B: Acute doxorubicin pulmotoxicity in rats with malignant neoplasm is effectively treated with fullerenol C60(OH)24 through inhibition of oxidative stress. Pharmacol Rep 61: 335-342, 2009.
26. Sordet O, Khan QA, Plo I, Pourquier P, Urasaki Y, Yoshida A, Antony S, Kohlhagen G, Solary E, Saparbaev M, Laval J and Pommier Y: Apoptotic topoisomerase I-DNA complexes induced by staurosporine-mediated oxygen radicals. J Biol Chem 279: 50499-50504, 2004.
27. Desagher S, Osen-Sand A, Nichols A, Eskes R, Montessuit S, Lauper S, Maundrell K, Antonsson B and Martinou JC: Bidinduced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol 144: 891-901, 1999.
28. Lemasters JJ, Nieminen AL, Qian T, Trost LC, Elmore SP, Nishimura Y, Crowe R A, Cascio WE, Bradham CA, Brenner DA and Herman B: The mitochondrial permeability transition in cell death: A common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta 1366: 177-196, 1998.
29. Nemoto S, Takeda K, Yu ZX, Ferrans VJ and Finkel T: Role for mitochondrial oxidants as regulators of cellular metabolism. Mol Cell Biol 20: 7311-7318, 2000.